FP essentials · 2016
Heart Failure Update: Outpatient Management.
Клинический случайСтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wojnowich Katherine, Korabathina Ravi
Аннотация
Outpatient management of heart failure (HF) is aimed at treating symptoms and preventing hospitalizations and readmissions. Management is initiated in a stepwise approach. Blockade of the renin-angiotensin system is a cornerstone of therapy and should be started, along with beta blockers, as soon as the diagnosis of HF is made. Other drugs, including diuretics, aldosterone antagonists, hydralazine, and nitrates, may be added based on symptoms and American College of Cardiology/American Heart Association stage. Despite a great interest in and theoretical benefit of naturoceutical products in the mitigation of oxidative stress and HF progression, none has been proven to be beneficial, and concerns exist regarding their interactions with standard HF drugs. Other nonpharmacologic interventions, including sodium restriction, regular exercise, and/or cardiac rehabilitation, should be initiated at diagnosis. HF often is progressive, and clinicians should be aware of late stage management options, including implantable devices, cardiac transplantation, and hospice care.
Предметные рубрики MeSH
Adrenergic beta-AntagonistsAgedAmbulatory CareAminobutyratesAngiotensin Receptor AntagonistsAngiotensin-Converting Enzyme InhibitorsBenzazepinesBiphenyl CompoundsCardiac Resynchronization TherapyCardiotonic AgentsCardiovascular AgentsDiet, Sodium-RestrictedDigoxinDiureticsDrug CombinationsExercise TherapyFatty Acids, Omega-3FemaleHeart FailureHeart TransplantationHospice CareHumansIvabradineMineralocorticoid Receptor AntagonistsTetrazolesValsartanVasodilator Agents